Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Henrik Ehlers Wulff
Age : 51
Public asset : 103,137 USD
Country of residence : Unknown
Linked companies : Novo Nordisk A/S - Ambu A/S

Biography of Henrik Ehlers Wulff 
Henrik Ehlers Wulff holds the position of Chairman for Novo Nordisk Pharmatech A. He is also on the board of Ambu An and Grundfos Holding An and Executive VP & Head-Information Technology at Novo Nordisk A. Mr. Wulff received a graduate degree from Technical University of Denmark.


Current positions of Henrik Ehlers Wulff 
Holdings of Henrik Ehlers Wulff 
Henrik Ehlers Wulff : Personal Network 
Most Read News 
07/27AMANCIO ORTEGA : Inditex founder Ortega buys 5% in Enagas's renewable, hydrogen unit
RE
07/29MARK ZUCKERBERG : Company's pandemic-era forecast was too rosy
RE
07/26MARK ZUCKERBERG : As Zuckerberg bets on TikTok-style videos, Meta heads for first-ever revenue drop
RE
07/29CATHIE WOOD : Wood's ARK fund on track for first monthly gain since Oct as risky stocks rally
RE
07/26ELON MUSK : Elon Musk asks judge for Twitter trial on Oct. 17, not Oct. 10
RE
08/02ELON MUSK : Twitter queries banks on Musk's attempts to undermine $44 billion deal
RE
07/28JACK MA : Jack Ma plans to give up control of Ant Group - WSJ
RE
08/06ELON MUSK : Musk says Twitter deal should go ahead if it provides proof of real accounts
RE
08/04JACK DORSEY : Dorsey-led Block posts loss for second quarter
RE
07/25Morgan Stanley's institutional equities head David Russell to retire
RE
More news


© 2022 People and Ownership :   
Henrik Ehlers Wulff : Connections 


Latest news about Henrik Ehlers Wulff 
03/03Novo Nordisk A/S - Analyst/Investor Day
CI
02/02TRANSCRIPT : Novo Nordisk A/S, 2021 Earnings Call, Feb 02, 2022
CI
2021TRANSCRIPT : Novo Nordisk A/S - Special Call
CI
2021TRANSCRIPT : Ambu A/S - Shareholder/Analyst Call
CI
2021Danish Pharmaceutical Company Novo Nordisk Expands at Home Via $2.6 Billion Investment on Manufacturing
MT
2020TRANSCRIPT : Novo Nordisk A/S - Special Call
CI
2020TRANSCRIPT : Ambu A/S - Shareholder/Analyst Call
CI
More news